rewirebio.iobenchmarks
Evidence claim

Relevance of Benet-Pages BRCA1/BRCA2 VUS reclassification: ENIGMA VCEP step (t3) to "Interpret BRCA1/BRCA2 germline variants"

Use case
Interpret BRCA1/BRCA2 germline variants
Assessed by
Benet-Pages BRCA1/BRCA2 VUS reclassification: ENIGMA VCEP step (t3)
Relevance
Proxy evidence
Endpoint
Fraction of the same 121-variant BRCA1/BRCA2 VUS cohort reclassified to benign/likely benign under the ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 (t3), applied after the ACMG/AMP + SVI step

A paired criteria-version reclassification step on the same fixed VUS cohort, applied after t2; it measures how many variants move off VUS under the ENIGMA VCEP specification, not classification accuracy against independent ground truth or reviewer time.

1 reviewed evaluation

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

15 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
1 values
  • source id
    uc-clinical-20261005-source-benet-pages
    locator
    Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
1 values
  • Same 121-variant VUS cohort reclassified across successive criteria-set versions (t1-t2-t3); this mapping covers only the ENIGMA VCEP step, applied after t2 on the same cohort.
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
Fraction of the same 121-variant BRCA1/BRCA2 VUS cohort reclassified to benign/likely benign under the ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 (t3), applied after the ACMG/AMP + SVI step
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
links:assessed_by:uc-clinical-20261005-benet-pages-t3-protocol
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Limitations
3 values
  • Paired criteria-version reclassification rate, not accuracy against independent ground truth or a reviewer-time comparison.
  • No independent clinical adjudication of individual calls.
  • The source's unresolved BRCA1/BRCA2 gene-split sentence (85% n=40 / 83% n=67) is not used in this mapping.
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Pinned records
6 values
  • record id
    uc-clinical-20261005-benet-pages-t3-evaluation
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    9c42ac261634c9b756fb7510104036842cada5b032ea8ad5052cc3e0649e8542
  • record id
    uc-clinical-20261005-benet-pages-t3-protocol
    fields
    • status
    • name
    • description
    • facets
    • source_ids
    • links
    • attributes
    sha256
    079ba6809f02cdeede889328b1551296c0eece1cb402a99edfee76f8215c7687
  • record id
    uc-clinical-20261005-benet-pages-t3-reclassified-b-lb-count
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    70cc29ab3474f36af3f20bf311a8818edc249d122a9183a2f85171377dcac1d2
  • record id
    uc-clinical-20261005-benet-pages-t3-reclassified-b-lb-fraction
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    80471ab18c38c165aa8aa541e432dfd0d014503f89c88f03e59ae2a6c471646e
  • record id
    uc-clinical-20261005-source-benet-pages
    fields
    • status
    • attributes.artifact_sha256
    sha256
    b5b89b5f7d8e1d2e8b0af3b4224510a0398b9777af95f6e730d88d4e360b7671
  • record id
    use-case-brca1-brca2-germline-interpretation
    fields
    • status
    • name
    • description
    • facets
    • attributes.question
    • attributes.decision
    • attributes.inputs
    • attributes.output
    • attributes.exclusions
    • attributes.setting
    • attributes.clinical_scope
    • attributes.intended_users
    sha256
    9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.pins

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Rationale
A paired criteria-version reclassification step on the same fixed VUS cohort, applied after t2; it measures how many variants move off VUS under the ENIGMA VCEP specification, not classification accuracy against independent ground truth or reviewer time.
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.rationale

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Reason
Add independently checked primary-source protocol evidence from the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343); scope the endpoint to paired criteria-version reclassification, not accuracy or review time.
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.reason

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Relevance
proxy
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.relevance

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Revision
1
Context-only references
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.revision

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-20261005-343-b3489257a74c

field
links:assessed_by:uc-clinical-20261005-benet-pages-t3-protocol
value
uc-clinical-20261005-benet-pages-t3-protocol
relevance
proxy
endpoint
Fraction of the same 121-variant BRCA1/BRCA2 VUS cohort reclassified to benign/likely benign under the ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 (t3), applied after the ACMG/AMP + SVI step
rationale
A paired criteria-version reclassification step on the same fixed VUS cohort, applied after t2; it measures how many variants move off VUS under the ENIGMA VCEP specification, not classification accuracy against independent ground truth or reviewer time.
constraints
Same 121-variant VUS cohort reclassified across successive criteria-set versions (t1-t2-t3); this mapping covers only the ENIGMA VCEP step, applied after t2 on the same cohort.
limitations
Paired criteria-version reclassification rate, not accuracy against independent ground truth or a reviewer-time comparison.; No independent clinical adjudication of individual calls.; The source's unresolved BRCA1/BRCA2 gene-split sentence (85% n=40 / 83% n=67) is not used in this mapping.
revision
1
reason
Add independently checked primary-source protocol evidence from the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343); scope the endpoint to paired criteria-version reclassification, not accuracy or review time.
citation locators
source id: uc-clinical-20261005-source-benet-pages; locator: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)
source locator
uc-clinical-20261005-source-benet-pages: Results, Reclassification of variants using the ENIGMA specifications (ENIGMA VCEP)
review
method: automated-source-review; reviewer: claude-sonnet; reviewer note: Claude Sonnet clinical coverage worker (research-evidence intake), root integration review; reviewed at: 2026-10-05T17:39:47.679Z; note: Source-backed literature curation with independent automated transcription and scope checks against the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343). No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
reviewed evaluations
uc-clinical-20261005-benet-pages-t3-evaluation
pins
record id: uc-clinical-20261005-benet-pages-t3-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: 9c42ac261634c9b756fb7510104036842cada5b032ea8ad5052cc3e0649e8542; record id: uc-clinical-20261005-benet-pages-t3-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: 079ba6809f02cdeede889328b1551296c0eece1cb402a99edfee76f8215c7687; record id: uc-clinical-20261005-benet-pages-t3-reclassified-b-lb-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 70cc29ab3474f36af3f20bf311a8818edc249d122a9183a2f85171377dcac1d2; record id: uc-clinical-20261005-benet-pages-t3-reclassified-b-lb-fraction; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 80471ab18c38c165aa8aa541e432dfd0d014503f89c88f03e59ae2a6c471646e; record id: uc-clinical-20261005-source-benet-pages; fields: status; attributes.artifact_sha256; sha256: b5b89b5f7d8e1d2e8b0af3b4224510a0398b9777af95f6e730d88d4e360b7671; record id: use-case-brca1-brca2-germline-interpretation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd
Related records

Suggest a correction